Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
5.78
-0.46 (-7.37%)
May 23, 2025, 12:40 PM - Market open
Kura Oncology Employees
Kura Oncology had 192 employees as of December 31, 2024. The number of employees increased by 50 or 35.21% compared to the previous year.
Employees
192
Change (1Y)
50
Growth (1Y)
35.21%
Revenue / Employee
$354,120
Profits / Employee
-$947,328
Market Cap
500.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
KURA News
- 19 hours ago - Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting - GlobeNewsWire
- 3 days ago - Kura Oncology to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress - GlobeNewsWire
- 17 days ago - Kura Oncology to Participate in Bank of America Securities Healthcare Conference - GlobeNewsWire
- 21 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - Kura Oncology, Inc. (KURA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Kura Oncology Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 25 days ago - Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST - GlobeNewsWire